@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAAKJEOOa_9Gs2lZJziFBYyk32yJErjyr5d_E0ob_b0oE> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAAKJEOOa_9Gs2lZJziFBYyk32yJErjyr5d_E0ob_b0oE#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix chebi: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=> .
@prefix schem: <http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/> .
@prefix RNA: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_33697> .
@prefix hgnc: <http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix mesh: <http://purl.bioontology.org/ontology/MSH/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 geneProductOf: hgnc:7873;
    a RNA: .
  
  sub:_2 rdf:object sub:_1;
    rdf:predicate belv:increases;
    rdf:subject schem:cytokine;
    a rdf:Statement .
  
  sub:_3 occursIn: mesh:D002467, obo:CL_0000576, obo:UBERON_0004237, species:9606;
    rdf:object sub:_2;
    rdf:predicate belv:increases;
    rdf:subject chebi:8228;
    a rdf:Statement .
  
  sub:assertion rdfs:label "a(CHEBI:pioglitazone) -> (a(SCHEM:cytokine) -> r(HGNC:NOS2))",
      "a(SCHEM:cytokine) -> r(HGNC:NOS2)" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_6;
    pav:version "20131211" .
  
  sub:_4 dce:identifier "Recuration of TZD simulation";
    dce:title "Recuration of TZD simulation";
    dce:type "Other" .
  
  sub:_5 prov:value "Pioglitazone (0.1 to 10 micromol/L) significantly enhanced cytokine-induced expression of iNOS and NO production in a dose-dependent manner in rat VSMCs, but 15-deoxy-Delta(12,14)-prostaglandin J2 (up to 10 micromol/L), a native peroxisome proliferator-activated receptor-gamma ligand, showed no effect. is translated to Activation of NOS2A (Homo sapiens) Gene Expression by Pioglitazone";
    prov:wasQuotedFrom sub:_4 .
  
  sub:_6 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource sub:_4;
    prov:wasDerivedFrom beldoc:, sub:_5 .
}

sub:pubinfo {
  this: dct:created "2014-07-03T14:31:28.378+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}